Loading clinical trials...
Loading clinical trials...
CP-675,206 is a fully human monoclonal antibody (mAb). It binds to the CTLA4 molecule, which is expressed on the surface of activated T lymphocytes. CP-675,206 is thought to stimulate patients' immune...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT05039801 · Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, and more
NCT04284774 · Malignant Solid Neoplasm, Recurrent Adrenal Gland Pheochromocytoma, and more
NCT04093323 · HLA-A2 Positive Cells Present, Refractory Melanoma
NCT06063746 · Refractory Melanoma
Research Site
Scottsdale, Arizona
Research Site
Bentonville, Arkansas
Research Site
Fayetteville, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions